You have 9 free searches left this month | for more free features.

Condition

Advanced Cancers (1)

Advanced Colorectal Carcinoma (1)

HIV (1)

Melanoma (1)

Small Cell Lung Cancer (1)

Overall Status

Completed (3)

Active, not recruiting (1)

Sign in for free

Phase

phase 2 (2)

phase 1 (1)

phase 1/phase 2 (1)

Sponsor

Mologen AG (2)

M.D. Anderson Cancer Center (1)

University of Aarhus (1)

Collaborator

Mologen AG (1)

Intervention

mgn1703 (4)

ipilimumab (1)

placebo (1)

standard of care (1)

Study Documents

Intervention Type

drug (4)

other (1)

Funder Type

Industry (2)

Other (2)

Study Type

Interventional (4)

mgn1703

Showing 1 - 4 of 4

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Advanced Cancers, Melanoma Trial in Houston (MGN1703, Ipilimumab)

Active, not recruiting

Advanced Cancers
Melanoma

MGN1703
Ipilimumab

Houston, Texas

University of Texas MD Anderson Cancer Center

Feb 11, 2022

Small Cell Lung Cancer Trial in Worldwide (MGN1703, Standard of care)

Completed

Small Cell Lung Cancer

MGN1703
Standard of care

Innsbruck, Austria
+3 more

Nov 13, 2018

HIV Trial in Aarhus N, Hvidovre (MGN1703)

Completed

HIV

MGN1703

Aarhus N, Denmark
+1 more

Jun 28, 2017

Advanced Colorectal Carcinoma Trial in Worldwide (MGN1703, Placebo)

Completed

Advanced Colorectal Carcinoma

MGN1703
Placebo

Wien, Austria
+11 more

Jun 19, 2014